1
|
Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.
|
Thorax
|
1998
|
2.71
|
2
|
Exhaled carbon monoxide in childhood asthma.
|
J Pediatr
|
1999
|
2.19
|
3
|
Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers.
|
Am J Respir Crit Care Med
|
2000
|
2.03
|
4
|
Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients.
|
Am J Respir Crit Care Med
|
1999
|
1.92
|
5
|
Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation.
|
Thorax
|
2004
|
1.68
|
6
|
Exhaled nitric oxide: a new lung function test.
|
Thorax
|
1996
|
1.64
|
7
|
Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress.
|
Thorax
|
1998
|
1.63
|
8
|
Exhaled nitric oxide in chronic obstructive pulmonary disease.
|
Am J Respir Crit Care Med
|
1998
|
1.60
|
9
|
Exhaled carbon monoxide and nitric oxide in COPD.
|
Chest
|
2001
|
1.58
|
10
|
Exhaled leukotrienes and prostaglandins in COPD.
|
Thorax
|
2003
|
1.55
|
11
|
Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD.
|
Thorax
|
2005
|
1.50
|
12
|
Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide.
|
Am J Respir Crit Care Med
|
1995
|
1.47
|
13
|
Adenosine 5'-monophosphate increases levels of leukotrienes in breath condensate in asthma.
|
Respir Med
|
2004
|
1.43
|
14
|
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease.
|
Eur Respir J
|
2003
|
1.42
|
15
|
Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases.
|
Am J Respir Crit Care Med
|
2001
|
1.41
|
16
|
Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma.
|
Am J Respir Crit Care Med
|
1998
|
1.34
|
17
|
Increased nitrotyrosine in exhaled breath condensate of patients with asthma.
|
Am J Respir Crit Care Med
|
2000
|
1.32
|
18
|
Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group.
|
Thorax
|
1998
|
1.27
|
19
|
Exhaled nitric oxide from lung periphery is increased in COPD.
|
Eur Respir J
|
2005
|
1.24
|
20
|
Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD.
|
Thorax
|
2003
|
1.23
|
21
|
Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease.
|
Am J Respir Crit Care Med
|
2000
|
1.21
|
22
|
Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke.
|
Thorax
|
2001
|
1.21
|
23
|
Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects.
|
Thorax
|
1998
|
1.20
|
24
|
Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia.
|
Eur Respir J
|
2003
|
1.19
|
25
|
Increased inflammatory markers in the exhaled breath condensate of cigarette smokers.
|
Eur Respir J
|
2003
|
1.16
|
26
|
Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis.
|
Thorax
|
2000
|
1.08
|
27
|
8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases.
|
Am J Respir Crit Care Med
|
1998
|
1.07
|
28
|
Elevation of exhaled ethane concentration in asthma.
|
Am J Respir Crit Care Med
|
2000
|
1.05
|
29
|
Exhaled carbon monoxide levels elevated in diabetes and correlated with glucose concentration in blood: a new test for monitoring the disease?
|
Chest
|
1999
|
1.05
|
30
|
Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis.
|
Thorax
|
1998
|
1.04
|
31
|
Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase.
|
Am J Respir Crit Care Med
|
1996
|
1.02
|
32
|
Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients.
|
Eur Respir J
|
1997
|
1.01
|
33
|
An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
|
Am J Respir Crit Care Med
|
1996
|
1.01
|
34
|
Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma.
|
Eur Respir J
|
1999
|
1.01
|
35
|
Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects.
|
Thorax
|
1998
|
1.00
|
36
|
Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress.
|
Thorax
|
1998
|
0.99
|
37
|
Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis.
|
Thorax
|
2000
|
0.98
|
38
|
The effect of alcohol ingestion on exhaled nitric oxide.
|
Eur Respir J
|
1996
|
0.97
|
39
|
Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype.
|
Chest
|
2000
|
0.96
|
40
|
Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis.
|
Eur Respir J
|
2001
|
0.95
|
41
|
Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia.
|
Thorax
|
2003
|
0.95
|
42
|
Increased carbon monoxide in exhaled air of patients with cystic fibrosis.
|
Thorax
|
1999
|
0.94
|
43
|
Exhaled carbon monoxide in patients with lower respiratory tract infection.
|
Respir Med
|
2001
|
0.93
|
44
|
Exhaled nitric oxide is increased in active fibrosing alveolitis.
|
Chest
|
1999
|
0.93
|
45
|
Real-time measurement of particulate matter deposition in the lung.
|
Biomarkers
|
2006
|
0.87
|
46
|
Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis.
|
J Allergy Clin Immunol
|
2000
|
0.87
|
47
|
Does exhaled nitric oxide reflect asthma control? Yes, it does!
|
Am J Respir Crit Care Med
|
2001
|
0.84
|
48
|
Increased vitronectin and endothelin-1 in the breath condensate of patients with fibrosing lung disease.
|
Respiration
|
2003
|
0.84
|
49
|
Exhaled and nasal nitric oxide is increased in laboratory animal allergy.
|
Clin Exp Allergy
|
1998
|
0.83
|
50
|
Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction.
|
Am J Respir Crit Care Med
|
2000
|
0.80
|
51
|
Exhaled carbon monoxide in lung disease.
|
Eur Respir J
|
2003
|
0.77
|
52
|
Local vasodilator response to mobile phones.
|
Laryngoscope
|
2001
|
0.77
|
53
|
Direct methods for the measurement of nitric oxide.
|
Monaldi Arch Chest Dis
|
2001
|
0.76
|
54
|
Feasibility and interpretation of FE(NO) measurements in asthma patients in general practice.
|
Respir Med
|
2008
|
0.75
|
55
|
Exhaled breath temperature in asthma.
|
Eur Respir J
|
2003
|
0.75
|
56
|
[Hyperbaric oxygenation in the treatment of dust bronchitis in coal miners].
|
Gig Tr Prof Zabol
|
1983
|
0.75
|
57
|
[Effect of hyperbaric oxygenation on central hemodynamics and oxygenating function of the lungs in open-heart surgery].
|
Fiziol Zh
|
1992
|
0.75
|
58
|
Measurement of exhaled hydrocarbons.
|
Methods Mol Med
|
2001
|
0.75
|
59
|
[Pachydermoperiostosis syndrome].
|
Klin Med (Mosk)
|
1986
|
0.75
|
60
|
[Use of hyperbaric oxygenation the treatment of Lyell's syndrome].
|
Vrach Delo
|
1984
|
0.75
|
61
|
[Bettolepsy (cough-cerebral syndrome) in the clinical picture of occupational diseases].
|
Ter Arkh
|
1986
|
0.75
|
62
|
[Experimental-clinical substantiation of treatment with hyperbaric oxygenation of patients with dust-induced bronchitis].
|
Vrach Delo
|
1985
|
0.75
|
63
|
[Effect of hyperbaric oxygenation on the exercise tolerance of patients with dust-induced bronchitis].
|
Sov Med
|
1984
|
0.75
|